BACKGROUND:Hispanic cancer patients are underrepresented in clinical trials; research suggests lack of knowledge and language barriers contribute to low accrual. Multimedia materials offer advantages to Hispanic populations because they have high acceptability, are easy to disseminate, and can be viewed with family. PURPOSE:Hispanic cancer patients and caregivers participated in focus groups toaid in developing a Spanish-language multimedia intervention to educate Hispanic cancer patients about clinical trials. We explored the feasibility of delivering the intervention in medical oncology clinics. METHODS: A total of 35 patients were randomized to either the multimedia intervention group (n = 18) or a control group (n = 17) who were asked to read the National Cancer Institute's Spanish-language clinical trials brochure. Self-reported data on knowledge about and attitudes toward clinical trials, self-efficacy for participating in a clinical trial, intention to participate in a clinical trial if asked, and receptivity to information about a clinical trial were collected at baseline and 10 days later. RESULTS: Delivery of the multimedia presentation in oncology clinics was feasible. The intervention group had more knowledge about clinical trials at follow-up than the control group; scores for intention to participate in a clinical trial by participants in the intervention group increased from 3.8 to 4.0 of a possible 5, but declined in the control group from 4.5 to 4.1. No statistically significant difference was detected between groups in scores for attitudes or self-efficacy for making a decision to participate in a clinical trial. LIMITATIONS: Our sample size was inadequate to identify differences between the informational methods. Although all patients were asked about their willingness to participate in a clinical trial, this decision was hypothetical. In addition, the study was conducted with a sample of Spanish-speaking Hispanic cancer patients at a comprehensive cancer center in Florida. Thus, the results may not generalize to other Hispanic populations. CONCLUSION: In the pilot project, we demonstrated the feasibility of delivering multimedia information to patients in medical oncology clinics. Because delivery in a clinical setting was found to be feasible, a larger study should be conducted to evaluate the efficacy of the multimedia intervention with respect to promoting accrual of Hispanic patients to clinical trials.
RCT Entities:
BACKGROUND: Hispanic cancerpatients are underrepresented in clinical trials; research suggests lack of knowledge and language barriers contribute to low accrual. Multimedia materials offer advantages to Hispanic populations because they have high acceptability, are easy to disseminate, and can be viewed with family. PURPOSE: Hispanic cancerpatients and caregivers participated in focus groups to aid in developing a Spanish-language multimedia intervention to educate Hispanic cancerpatients about clinical trials. We explored the feasibility of delivering the intervention in medical oncology clinics. METHODS: A total of 35 patients were randomized to either the multimedia intervention group (n = 18) or a control group (n = 17) who were asked to read the National Cancer Institute's Spanish-language clinical trials brochure. Self-reported data on knowledge about and attitudes toward clinical trials, self-efficacy for participating in a clinical trial, intention to participate in a clinical trial if asked, and receptivity to information about a clinical trial were collected at baseline and 10 days later. RESULTS: Delivery of the multimedia presentation in oncology clinics was feasible. The intervention group had more knowledge about clinical trials at follow-up than the control group; scores for intention to participate in a clinical trial by participants in the intervention group increased from 3.8 to 4.0 of a possible 5, but declined in the control group from 4.5 to 4.1. No statistically significant difference was detected between groups in scores for attitudes or self-efficacy for making a decision to participate in a clinical trial. LIMITATIONS: Our sample size was inadequate to identify differences between the informational methods. Although all patients were asked about their willingness to participate in a clinical trial, this decision was hypothetical. In addition, the study was conducted with a sample of Spanish-speaking Hispanic cancerpatients at a comprehensive cancer center in Florida. Thus, the results may not generalize to other Hispanic populations. CONCLUSION: In the pilot project, we demonstrated the feasibility of delivering multimedia information to patients in medical oncology clinics. Because delivery in a clinical setting was found to be feasible, a larger study should be conducted to evaluate the efficacy of the multimedia intervention with respect to promoting accrual of Hispanic patients to clinical trials.
Authors: Marcia E Bouton; Gina R Shirah; Jesse Nodora; Erika Pond; Chiu-Hsieh Hsu; Anne E Klemens; Maria Elena Martinez; Ian K Komenaka Journal: J Surg Oncol Date: 2011-08-31 Impact factor: 3.454
Authors: Evelyn C Y Chan; Stephanie L McFall; Theresa L Byrd; Patricia Dolan Mullen; Robert J Volk; John Ureda; Jessica Calderon-Mora; Pat Morales; Adriana Valdes; L Kay Bartholomew Journal: Patient Educ Couns Date: 2011-01-14
Authors: Paul B Jacobsen; Kristen J Wells; Cathy D Meade; Gwendolyn P Quinn; Ji-Hyun Lee; William J Fulp; Jhanelle E Gray; Rachid C Baz; Gregory M Springett; Richard M Levine; Merry-Jennifer Markham; Fred J Schreiber; Thomas H Cartwright; James M Burke; Robert D Siegel; Mokenge P Malafa; Daniel Sullivan Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Gwendolyn P Quinn; Jessica McIntyre; Luis E Gonzalez; Teresita Muñoz Antonia; Prado Antolino; Kristen J Wells Journal: J Health Commun Date: 2013-05-02
Authors: M Lizette Rangel; Natalia I Heredia; Belinda Reininger; Lorna McNeill; Maria E Fernandez Journal: J Cancer Educ Date: 2019-12 Impact factor: 2.037
Authors: Vivian M Rodríguez; Erika Robers; Kate Zielaskowski; C Javier González; Keith Hunley; Kimberly A Kaphingst; Dolores D Guest; Andrew Sussman; Kirsten A Meyer White; Matthew R Schwartz; Jennie Greb; Yvonne Talamantes; Jessica Bigney; Marianne Berwick; Jennifer L Hay Journal: J Community Genet Date: 2016-12-06
Authors: Christian M Simon; Kai Wang; Laura A Shinkunas; Daniel T Stein; Paul Meissner; Maureen Smith; Rebecca Pentz; David W Klein Journal: J Empir Res Hum Res Ethics Date: 2021-08-19 Impact factor: 1.742
Authors: Y M Rivera; H Vélez; J Canales; J C Jiménez; L Moreno; J Torres; S T Vadaparampil; T Muñoz-Antonia; G P Quinn Journal: J Cancer Educ Date: 2016-12 Impact factor: 2.037